Keros Therapeutics, Inc. - KROS
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q2 2026
· Q1 2026
Value (USD)
Total reported value ($000)
$198.8M
QoQ value delta ($000)
-$10.35M
(-4.95%)
Implied price effect (QoQ)
-3.18%
Shares
Total shares
18,579,556
QoQ shares delta
-345,368
(-1.82%)
Total shares held by funds (by quarter)
Market chart (KROS)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q2 2026)
Top 25 only
Full list
Partial Q2 2026 data: 133 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.